Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended
	Feb. 23, 2020	Dec. 31, 2021	Jun. 30, 2021
Clinical Studies [Member]
Accrued research and development expenses		$ 1,486,000	$ 1,486,000
Common Class A [Member]
Options to purchase shares	500,000
Exercise price	$ 0.10
Exercise price description	Class A common stock at an exercise price of $0.10 per share, which is 110% of the previous per share closing price of $0.09 on February 21, 2020
Zorik Spektor [Member] | Common Class A [Member]
Common stock, Shares issued	500,000